생쥐 수지상세포에서 발현하는 CD11c 프로모터의 규명
Characterization of the CD11c Promoter Which Is Expressed in the Mou se Dendritic Cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: CD11c, also known as integrin alpha x, is one of the optimum markers of dendritic cells. However, the regulation of the CD11c expression in mouse has not been identified yet. In this study, in order to analyze the regulation of CD11c expression, the promoter of CD11c was cloned and characterized. Methods: To identify the promoter portion, various sizes of what are considered to be CD11c promoter fragments was amplified by polymerase chain reaction (PCR), using mouse genomic DNA as a template. After sequence was obtained, these fragments were transfected into various cell lines including mouse dendritic cell lines such as JAWSII and DC2.4 and L929 as control cell line.. The promoter activity of three promoter fragments was measured and compared by luciferase activity in the transfected cells. Results: Three clones with size of 1kb, 3kb and 6kb were obtained from mouse genomic DNA. Flow cytometry analysisof JAWSII cells revealed that 52% of the cells expressed CD11c, which was conf irmed by RT-PCR analysis. On the contrary, L929 and DC 2.4 cells did not express CD11c. The CD11c+ JAWSII cells were enriched from 52% to 90% with cell sorter. The comparative luciferase activity analyisis demonstrated that the region responsible for tissue specific expression was contained within −3 kb and the clone with size of 3 kb particularly showed higher luciferase activity than 6 kb and 1 kb clones. Conclusion: The CD11c promoter region containing the region responsible for tissue specificity was successfully cloned and −3 kb region showed the highest activity.
Abstract
Background: CD11c, also known as integrin alpha x, is one of the optimum markers of dendritic cells. However, the regulation of the CD11c expression in mouse has not been identified yet. In this study, in order to analyze the regulation of CD11c expression, the promoter of CD11c was cloned and characterized. Methods: To identify the promoter portion, various sizes of what are considered to be CD11c promoter fragments was amplified by polymerase chain reaction (PCR), using mouse genomic DNA as a template. After sequence was obtained, these fragments were transfected into various cell lines including mouse dendritic cell lines such as JAWSII and DC2.4 and L929 as control cell line.. The promoter activity of three promoter fragments was measured and compared by luciferase activity in the transfected cells. Results: Three clones with size of 1kb, 3kb and 6kb were obtained from mouse genomic DNA. Flow cytometry analysisof JAWSII cells revealed that 52% of the cells expressed CD11c, which was conf irmed by RT-PCR analysis. On the contrary, L929 and DC 2.4 cells did not express CD11c. The CD11c+ JAWSII cells were enriched from 52% to 90% with cell sorter. The comparative luciferase activity analyisis demonstrated that the region responsible for tissue specific expression was contained within −3 kb and the clone with size of 3 kb particularly showed higher luciferase activity than 6 kb and 1 kb clones. Conclusion: The CD11c promoter region containing the region responsible for tissue specificity was successfully cloned and −3 kb region showed the highest activity.
참고문헌 (26)
- Lanier LL, "p150", 95, third member of the LFA-1, Eur J Immunol, pp.1985, 15[DOI]
- Springer TA, "p150,95, the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family", J Immunol, 136, pp.240~245 (1986)
- Sanchez-Madrid F, "A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1", Mac-1), and the p150,95 molecule, 1983, pp.158, 1785~1803
- Corbi AL, "cDNA cloning and complete primary structure of the alpha subunit of a leukocyte adhesion glycoprotein, p150,95", EMBO J, 6, pp.4023~4028 (1987)
- Malhotra V, "Ligand binding by the p150,95 antigen of U937 monocytic cells: properties in common with complement receptor type 3 (CR3)", Eur J Immunol, 16, pp.1117~1123 (1986)
- Keizer GD, "Role of p150,95 in adhesion, migration, chemotaxis and phagocytosis of human monocytes", Eur J Immunol, 17, pp.1317~1322 (1987)
- Hogg N, "The p150,95 molecule is a marker of human mononuclear phagocytes: comparison with expression of class II molecules", Eur J Immunol, 16, pp.240~248 (1986)
- Winkel K, "CD4 and CD8 expression by human and mouse thymic dendritic cells", Immunol Lett, 40, pp.93~99 (1994)
- Metlay JP, "The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies", J Exp Med, 171, pp.1753~1771 (1990)
- Agger R, "The surface of dendritic cells in the mouse as studied with monoclonal antibodies", Int Rev Immunol, 6, pp.89~101 (1990)
- Shelley CS, "During differentiation of the monocytic cell line U937, Pur alpha mediates induction of the CD11c beta 2 integrin gene promoter", J Immunol, 168, pp.3887~3893 (2002)
- López-Cabrera M, "Characterization of the p150,95 leukocyte integrin alpha subunit (CD11c) gene promoter. Identification of cis-acting elements", J Biol Chem, 268, pp.1187~1193 (1993)
- Lopez-Rodriguez C, "CCAAT-enhancer-binding proteins (C", EBP) regulate the tissue specific activity of the CD11c integrin gene promoter through functional interactions with Sp1 proteins, 1997, pp.272, 29120~29126
- Lopez-Rodriguez C, "PU.1 negatively regulates the CD11c integrin gene promoter through recognition of the major transcriptional start site", Eur J Immunol, 27, pp.1843~1847 (1997)
- Bell D, "Dendritic cells", Adv Immunol, 72, pp.255~324 (1999)
- Jung S, "In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens", Immunity, 17, pp.211~220 (2002)
- Brocker T, "Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo", J Exp Med, 185, pp.541~550 (1997)
- Arthur JF, "A comparison of gene transfer methods in human dendritic cells", Cancer Gene Ther, 4, pp.17~25 (1997)
- Diebold SS, "Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells", J Biol Chem, 274, pp.19087~19094 (1999)
- Diebold SS, "Efficient gene delivery into human dendritic cells by adenovirus polyethylenimine and mannose polyethylenimine transfection", Hum Gene Ther, 10, pp.775~786 (1999)
- Strobel I, "Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes", Gene Ther, 7, pp.2028~2035 (2000)
- Irvine AS, "Efficient nonviral transfection of dendritic cells and their use for in vivo immunization", Nat Biotechnol, 18, pp.1273~1278 (2000)
- Lohmann S, "CD83+ human dendritic cells transfected with tumor peptide cDNA by electroporation induce specific T-cell responses: a potential tool for gene immunotherapy", Cancer Gene Ther, 7, pp.605~614 (2000)
- Van Tendeloo VF, "Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells", Gene Ther, 5, pp.700~707 (1998)
- Awasthi S, "Transfection of murine dendritic cell line (JAWS II) by a nonviral transfection reagent", Biotechniques, 35, pp.600~602 (2003)
- Shen Z, "Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules", J Immunol, 158, pp.2723~2730 (1997)